SCHEMBL17667129

SCHEMBL17667129

CC1(C)c2ccc(-c3ccc(N(c4ccccc4)c4ccc(-c5ccccc5)cc4)cc3)cc2-c2c1c1ccccc1n2-c1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ IL1R1 P14778 1/20 0.36
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TSPO P30536 1/20 0.32
▸ MAPK8 P45983 1/20 0.32
▸ GSK3B P49841 1/20 0.31
▸ CAMK2D Q13557 1/20 0.30
▸ RARA P10276 1/20 0.30
▸ RARB P10826 1/20 0.30
▸ RARG P13631 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17710607 0.99 IL1R1 (0.37) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667123 0.99 IL1R1 (0.37) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667122 0.98 IL1R1 (0.34) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667107 0.97 IL1R1 (0.34) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667141 0.94 IL1R1 (0.37) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667120 0.93 IL1R1 (0.33) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667117 0.92 CA12 (0.36) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667127 0.91 IL1R1 (0.32) IL1R1L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL17667119 0.91 PDK2 (0.30) IL1R1L3MBTL1KDM4EATM
SCHEMBL17667136 0.90 PDK2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3006426-B1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2019-01-09 — — EP disclosed
US-9985216-B2 Indenoindole derivative and organic electroluminescent element HODOGAYA CHEMICAL CO., LTD. (JP) 2018-05-29 — — US disclosed
US-20160126468-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2016-05-05 — — US disclosed
EP-3006426-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2016-04-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160126468-A1 INDENOINDOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT IDO2, SLCO2B1, IDO1 IL1R1 2572/4885L3MBTL1 2737/4885KMT2A 2447/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback